SEC Filing Details

Document Details

Form
Filing Date
Oct 6, 2016
Document Date
Oct 6, 2016
Form Description
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3
Filing Group
Registration Statements
Company
Obalon Therapeutics
Issuer
OBALON THERAPEUTICS INC
IMPORTANT SAFETY INFORMATION
The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible. The most common side effects reported were mild abdominal pain and nausea which typically resolved within two weeks. You must take daily acid-blocking medicine prescribed by your doctor. For full Important Safety Information click onSafety Information and Patient Labeling